Device Settlements Contribute To DoJ's $2.5Bn Health-Care FCA Haul

The US Department of Justice collected $2.8bn in settlements and judgments involving violations of the False Claims Act in 2018, including $2.5bn in health-care cases. Key device industry recoveries included $33.2m from Alere, $12.5m from Angiodynamics, and $30m in two separate settlements from Covidien and its subsidiary ev3.

United States Department of Justice headquarter building in Washington D.C. — US Department of Justice

The devices and diagnostics industries contributed at least $86.1m in settlements to the US Department of Justice’s fiscal 2018 False Claims Act haul of $2.8bn, data released by the agency shows.

Of the overall $2.8bn, $2.5bn came from the health-care industry, including settlements from drug and device manufacturers, insurers, health care...